Metabolic safety of growth hormone in type 1 diabetes and idiopathic growth hormone deficiency.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To evaluate metabolic consequences of growth hormone (GH) treatment in children with type 1 diabetes.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J. Pediatr.

Title: The Journal of pediatrics

Publisher: Elsevier BV

ISSN (Electronic): 1097-6833

ISSN (Print): 0022-3476

Publication date (Electronic): Oct 2013

Volume: 163

Issue: 4

Affiliations

[1 ] Division of Pediatric Endocrinology, Department of Pediatrics, Technical University München, Munich, Germany. Electronic address: Walter.Bonfig@lrz.tum.de.

Article

Publisher Item ID: S0022-3476(13)00510-6

DOI: 10.1016/j.jpeds.2013.04.045

PubMed ID: 23746867

SO-VID: 89af63f4-61f3-49ac-b379-edc403a96be7

History

Keywords: Diabetes Patienten Verlaufsdocumentationsystem,GH,Growth hormone,H-SDS,HbA1c,Height-SDS,Hemoglobin A1c,IGF,Insulin-like growth factor,DPV

Data availability:

Keywords: Diabetes Patienten Verlaufsdocumentationsystem, GH, Growth hormone, H-SDS, HbA1c, Height-SDS, Hemoglobin A1c, IGF, Insulin-like growth factor, DPV

Metabolic safety of growth hormone in type 1 diabetes and idiopathic growth hormone deficiency.

Read this article at

Abstract

Related collections

Karger: Endocrinology

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Cited by 7